Stifel raised the firm’s price target on Celestica (CLS) to $385 from $230 and keeps a Buy rating on the shares after the company reported “strong” Q3 results, raised its FY25 revenue and EPS outlook and initiated a FY26 forecast. Leverage is improving modestly and the firm expects more to come, longer-term, says the analyst, who argues that Celestica remains “a top pick to capitalize on the AI infrastructure build-out.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLS:
- Celestica price target raised to $305 from $238 at TD Securities
- Celestica price target raised to $370 from $300 at BMO Capital
- Celestica price target raised to $440 from $340 at Goldman Sachs
- Celestica price target raised to $388 from $305 at JPMorgan
- Celestica price target raised to $357 from $220 at Barclays
